​

scPharmaceuticals (SCPH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SCPH Stock Forecast

scPharmaceuticals (SCPH) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $13.00, with a high of $13.00 and a low of $13.00. This represents a 295.14% increase from the last price of $3.29.

$3 $5 $7 $9 $11 $13 High: $13 Avg: $13 Low: $13 Last Closed Price: $3.29

SCPH Stock Rating

scPharmaceuticals stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

SCPH Forecast vs Benchmarks

TypeNameUpside
StockscPharmaceuticals295.14%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$13.00$13.00
Last Closing Price$3.29$3.29$3.29
Upside/Downside-295.14%295.14%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2524---6
Dec, 2424---6
Nov, 2424---6
Oct, 2424---6
Sep, 2424---6
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Glen SantangeloJefferies$13.00$3.81241.21%295.14%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2024JefferiesBuyBuyhold
Oct 23, 2024Cowen & Co.BuyBuyhold
Oct 11, 2022SVB LeerinkOutperformupgrade

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.42-----
Avg Forecast$-1.49$-1.81$-0.94$0.27$1.34$1.94
High Forecast$-1.56$-1.93$-1.13$-0.29$0.20$1.67
Low Forecast$-1.37$-1.73$-0.72$1.19$2.06$2.32
Surprise %-4.70%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.59M-----
Avg Forecast$13.02M$36.28M$84.08M$167.31M$249.68M$283.45M
High Forecast$11.63M$36.09M$76.21M$167.31M$223.00M$253.17M
Low Forecast$15.00M$36.54M$97.41M$167.31M$287.74M$326.66M
Surprise %4.40%-----

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-54.81M-----
Avg Forecast$-54.81M$-70.44M$-35.77M$13.59M$70.91M$74.72M
High Forecast$-60.23M$-74.31M$-43.67M$-11.14M$7.70M$64.34M
Low Forecast$-52.65M$-66.58M$-27.88M$45.73M$79.34M$89.52M
Surprise %------

SCPH Forecast FAQ

Is scPharmaceuticals stock a buy?

scPharmaceuticals stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that scPharmaceuticals is a favorable investment for most analysts.

What is scPharmaceuticals's price target?

scPharmaceuticals's price target, set by 3 Wall Street analysts, averages $13 over the next 12 months. The price target range spans from $13 at the low end to $13 at the high end, suggesting a potential 295.14% change from the previous close price of $3.29.

How does scPharmaceuticals stock forecast compare to the average forecast of its sector, industry, and investment themes?

scPharmaceuticals stock forecast shows a 295.14% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for scPharmaceuticals over the past three months?

  • January 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is scPharmaceuticals’s EPS forecast?

scPharmaceuticals's average annual EPS forecast for its fiscal year ending in December is -1.81 for 2024, a 27.46% increase from the reported $-1.42 in 2023. The prediction for 2025 is $-0.94, $0.27 for 2026, $1.34 for 2027, and $1.94 for 2028.

What is scPharmaceuticals’s revenue forecast?

scPharmaceuticals's average annual revenue forecast for its fiscal year ending in December is $36.28M for 2024, a 166.90% increase from the reported $13.59M in 2023. The forecast for 2025 is $84.08M, $167.31M for 2026, $249.68M for 2027, and $283.45M for 2028.

What is scPharmaceuticals’s net income forecast?

For its fiscal year ending in December, scPharmaceuticals's average annual net income forecast is $-70.444M for 2024, reflecting an 28.52% increase from the reported $-54.81M in 2023. The projection for 2025 is $-35.772M, $13.58M for 2026, $70.91M for 2027, and $74.72M for 2028.